Vanderbilt University Medical Center Research Fatal Toxicity with Immunotherapy Increasing

TrialsiteN

Pam Harrison of Medscape reports that Fatal toxic effects from immune checkpoint inhibitors (ICIs) are rare, but clinicians need to be aware of the diverse toxic effects that these drugs can have in as much as the use of these agents is rapidly increasing, a systematic review and meta-analysis concludes. “Toxic effects associated with ICIs may affect any organ, and stem from activation of autoreactive T cells damaging host tissues,” write the authors, led by Daniel Wang, MD, Vanderbilt University Medical Center, Nashville, Tennessee.

Lead Research/Investigator, Daniel Wang, MD

https://medicine.mc.vanderbilt.edu/current-hemonc-fellows